Federal contract award
W81K0021P0235
GN/AST GENERIC GN AST 20 CARDS/BOX
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRC0 WEST |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6515 — Medical and Surgical Instruments, Equipment, and Supplies |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $619.5K |
| Current contract value | $737.2K |
| Potential contract value / ceiling | $737.2K |
| Start date | Oct 1, 2021 |
| Current end date | Sep 30, 2026 |
| Potential end date | Sep 30, 2026 |
| Latest award activity | May 12, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 19 of 19 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 12, 2026 | P00018 | $-232.4K | THE PURPOSE FOR THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FY26 FUNDS, IN ORDER TO REFLECT ACTUAL AMOUNTS USED DURING PERFORMANCE OF THE PURCHASE ORDER IN FY26 (01 OCTOBER 2025 - 30 SEPTEMBER 2026). |
| Feb 24, 2026 | P00017 | $-406.6K | THE PURPOSE FOR THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FY22 FUNDS, IN ORDER TO REFLECT ACTUAL AMOUNTS USED DURING PERFORMANCE OF THE PURCHASE ORDER IN FY22 (01 OCTOBER 2021 - 30 SEPTEMBER 2022. |
| Feb 2, 2026 | P00016 | $-201.5K | THE PURPOSE FOR THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FY25 FUNDS, IN ORDER TO REFLECT ACTUAL AMOUNTS USED DURING PERFORMANCE OF THE PURCHASE ORDER IN FY25 (01 OCTOBER 2024 - 30 SEPTEMBER 2025. |
| Dec 3, 2025 | P00015 | $364.7K | IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K00-21-P-0235 FOR THE PERIOD OF 1 OCTOBER 2025 - 30 SEPTEMBER 2026. |
| Sep 17, 2025 | P00014 | $-55.3K | THE PURPOSE FOR THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FY24 FUNDS, IN ORDER TO REFLECT ACTUAL AMOUNTS USED DURING PERFORMANCE OF THE CONTRACT IN FY24 (01 OCTOBER 2023 - 30 SEPTEMBER 2024. |
| Jul 2, 2025 | P00013 | $0 | PURSUANT TO FEDERAL ACQUISITION REGULATION (FAR) 52.217-9, OPTION TO EXTEND THE TERM OF THE CONTRACT, W81K00-21-P-0235 WITH BIOMERIEUX, INC. IS HEREBY EXTENDED FOR THE PERIOD 01 OCTOBER 2025 - 30 SEPTEMBER 2026 (OPTION PERIOD 4). |
| May 27, 2025 | P00012 | $-258.8K | THE PURPOSE FOR THIS MODIFICATION IS TO DE-OBLIGATE EXCESS FY23 FUNDS, IN ORDER TO REFLECT ACTUAL AMOUNTS USED DURING PERFORMANCE OF THE CONTRACT IN FY23 (01 OCTOBER 2022 - 30 SEPTEMBER 2023. |
| Jan 8, 2025 | P00011 | $364.7K | GN/AST GENERIC GN AST 20 CARDS/BOX - FY25 FUNDING MODIFICATION |
| Sep 20, 2024 | P00010 | $-201.8K | GN/AST GENERIC GN AST 20 CARDS/BOX |
| Sep 16, 2024 | P00009 | $0 | GN/AST GENERIC GN AST 20 CARDS/BOX |
| Aug 1, 2024 | P00008 | $0 | GN/AST GENERIC GN AST 20 CARDS/BOX - INCREASE & DECREASE IN QUANTITIES. |
| Nov 27, 2023 | P00007 | $415.5K | GN/AST GENERIC GN AST 20 CARDS/BOX - FUNDING MODIFICATION |
| May 17, 2023 | P00006 | $0 | GN/AST GENERIC GN AST 20 CARDS/BOX |
| Nov 9, 2022 | P00005 | $415.5K | GN/AST GENERIC GN AST 20 CARDS/BOX - FY23 FUNDING ACTION |
| Aug 31, 2022 | P00004 | $415.5K | GN/AST GENERIC GN AST 20 CARDS/BOX - ADD WAWF FUNDING |
| Aug 22, 2022 | P00003 | $0 | GN/AST GENERIC GN AST 20 CARDS/BOX |
| Jun 1, 2022 | P00002 | $0 | GN/AST GENERIC GN AST 20 CARDS/BOX - ADDITIONAL VITEK INSTRUMENT |
| Nov 4, 2021 | P00001 | $0 | GN/AST GENERIC GN AST 20 CARDS/BOX |
| Aug 23, 2021 | 0 | $0 | GN/AST GENERIC GN AST 20 CARDS/BOX |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.